Banque Cantonale Vaudoise’s BioLineRX BLRX Stock Holding History

Banque Cantonale Vaudoise’s Portfolio BLRX Stock Details BLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$0	Hold	1	–	–	﹤0.01%	877
2025 Q4	$0	Buy	+1	New	+$3	﹤0.01%	824

Other funds holding BLRX

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

NRG

Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Banque Cantonale Vaudoise's BLRX Position: Q1 2026 in Review

Banque Cantonale Vaudoise held its BioLineRX (BLRX) position steady in Q1 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #877.

Banque Cantonale Vaudoise first reported a position in BLRX in Q4 2025 and has held it in 2 quarters since. 13 funds tracked by Wall St. Rank hold BLRX as of Q1 2026.

Banque Cantonale Vaudoise held 1 share of BioLineRX worth $0 as of Q1 2026.
Banque Cantonale Vaudoise left its BioLineRX share count unchanged in Q1 2026.
BioLineRX made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q1 2026, its #877 holding.
Banque Cantonale Vaudoise first reported a position in BioLineRX in Q4 2025 and has held it in 2 quarters since.
13 funds tracked by Wall St. Rank held BioLineRX as of Q1 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2026, filed 20 Apr 2026.